Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

COVID-19 6Neoplasms 2Hematologic Neoplasms 2Severe Acute Respiratory Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mastocytosis 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypersensitivity 1Hematopoietic and Lymphatic System Neoplasm 1Chronic Disease 1

Interventions

Interviews as Topic 13Specimen Handling 11Practice Guidelines as Topic 9Standard of Care 8Educational Status 7Methods 5Early Intervention, Educational 5Patient Navigation 4Health Promotion 3Acupressure 3Telemedicine 2Restraint, Physical 2Resistance Training 2Behavior Therapy 2Aromatherapy 2theanine 1ruxolitinib 1merphos 1lavender oil 1jojoba wax 1axatilimab 1X-Rays 1Triptorelin Pamoate 1Tacrolimus 1Surveys and Questionnaires 1Stem Cell Transplantation 1Spiritual Therapies 1Spinal Puncture 1Psychotherapy 1Psilocybin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematopoietic and Lymphatic System Neoplasm × BNT162 Vaccine × Clear all
NCT07390968 2026-02-09

Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients

Fred Hutchinson Cancer Center

Phase 2 Not yet recruiting
56 enrolled

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡